Development of a recombinant zika virus vaccine based on subunit envelope (e) amtigen fused to a TLR5 agonist (flagellin)
Ended Project Grant Awarded Last action
- Award ID
- R21AI128960
- Recipient
-
Vaxinnate Corporation UEI K61HKG4JFH99
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $110,046
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Funding agency
- Department of Health and Human Services
- Place of performance
- Cranbury, NJ, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$8,215 | |
| Amendment | -$96,052 | |
| Original award | $214,313 |
Quick answers
Who received award R21AI128960?
R21AI128960 was awarded to Vaxinnate Corporation by National Institutes of Health (Department of Health and Human Services) on August 18, 2016.
How much is award R21AI128960 worth?
$110,046 has been obligated on R21AI128960.
Which agency awarded R21AI128960?
National Institutes of Health (Department of Health and Human Services) awarded R21AI128960, with funding from Department of Health and Human Services.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award